Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis

Clinical trial NCT00814073 · COMPLETED

Trial details

NCT number: NCT00814073
Sponsor: AB Science
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Indolent Systemic Mastocytosis

Start date: 2008-12-01
Primary completion: 2015-11-01
Enrollment: 135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.